QA: Alpine Immune Sciences INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2020_Alpine_Immune_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001626199, Alpine Immune Sciences INC

  xvar xval
0 AssetsCurrent 42,302,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,552,000
3 remainder_Assets 10,239,000
4 LiabilitiesCurrent 8,681,000
5 LiabilitiesNoncurrent 15,938,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,551,389
9 ResearchAndDevelopmentExpense 35,211,944
10 remainder_Expenses 745,199
11 remainder_Revenues 3,482,279
12 remainder_NetIncome 778,324
13 remainder_ComprehensiveNetIncome 30,071
  yvar yval
0 Assets 54,093,000
1 Liabilities 24,619,000
2 Expenses 45,508,532
3 Revenues 3,482,279
4 StockholdersEquity 29,474,000
5 NetIncome -41,247,929
6 ComprehensiveNetIncome -41,232,894
7 BaseVar 64,255,603
8 EconomicCapitalRatiobeforeLimitedLiability 0.585
9 EconomicCapitalRatio 1.96

Edgar->Model Mapping

Feature Distribution

Change over Time